pioglitazone has been researched along with Ocular Infections in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva-Abreu, M | 1 |
| Calpena, AC | 1 |
| Espina, M | 1 |
| Silva, AM | 1 |
| Gimeno, A | 1 |
| Egea, MA | 1 |
| García, ML | 1 |
1 other study available for pioglitazone and Ocular Infections
| Article | Year |
|---|---|
Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availabilit | 2018 |